Duchenne Muscular Dystrophy clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab's safety and efficacy in non-ambulatory subjects with DMD.
San Francisco, California and other locations